Home Ingredients R-Lipoic Acid (Natural / Stabilized R-ALA)
Metabolic HealthAntioxidantLongevity

R-Lipoic Acid (Natural / Stabilized R-ALA)

Evidence Level
Strong
2 Clinical Trials
5 Documented Benefits
4/5 Evidence Score

R-Lipoic Acid (R-ALA) is the biologically ACTIVE enantiomer of alpha-lipoic acid — the naturally occurring form in mitochondria. Distinct from racemic ALA (50/50 R/S mixture) which is the standard cheap supplement. R-ALA is roughly twice as potent as racemic ALA per mg. Stabilized R-ALA forms (Na-RALA, BioEnhanced® R-Lipoic Acid) overcome stability issues. Used for diabetic neuropathy, antioxidant support, and metabolic health.

Studied Dose 100-300 mg/day R-ALA (equivalent to ~200-600 mg racemic ALA); diabetic neuropathy 600 mg/day racemic or ~300 mg R-ALA; up to 1,200 mg/day racemic studied in trials
Active Compound (R)-(+)-alpha-lipoic acid (R-ALA / R-LA)

Benefits

Diabetic Peripheral Neuropathy

Alpha-lipoic acid has the strongest evidence base for any natural compound for diabetic peripheral neuropathy. Sydney 2 trial, ALADIN III, and others established efficacy. R-ALA is the active enantiomer; racemic ALA contains 50% S-form which has minimal activity. Most clinical trials used racemic but R-ALA is the active component.

Supported by Trial 1

Antioxidant Activity (Both Water and Lipid Soluble)

ALA is unique among antioxidants in being both water-soluble and lipid-soluble — accesses both cellular environments. Recycles other antioxidants (vitamin C, vitamin E, glutathione, CoQ10). 'Universal antioxidant' positioning.

Supported by Trial 2

Insulin Sensitivity / Blood Sugar

Improves insulin sensitivity in T2DM and metabolic syndrome. Ansar 2011 and others showed modest glycemic effects. Effect modest; not substitute for evidence-based diabetes medications.

Supported by Trial 2

Mitochondrial Function

Endogenous mitochondrial cofactor for pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase complexes. Supports cellular energy production.

Heavy Metal Chelation

ALA chelates heavy metals (mercury, arsenic, cadmium) — used in chelation protocols by some practitioners. Modest evidence; not first-line for clinical heavy metal toxicity.

Supported by Trial 1, Trial 2

Mechanism of action

1

Endogenous Mitochondrial Cofactor

R-ALA is the naturally-occurring enantiomer in mitochondria — bound to specific lysine residues on enzymes (lipoyllysine). Cofactor for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain ketoacid dehydrogenase, glycine cleavage system.

2

R-ALA vs S-ALA Activity

R-form is biologically active; S-form has minimal direct biological activity. Racemic ALA (50/50 mix) effectively delivers half the active dose at same mg quantity. PURE R-ALA is therefore approximately twice as potent per mg.

3

Glutathione Recycling

ALA reduces oxidized glutathione (GSSG) back to active GSH — supporting endogenous antioxidant capacity beyond just direct ALA antioxidant effects.

4

AMPK Activation

Activates AMP-activated protein kinase (AMPK) — improving glucose uptake, insulin sensitivity, fat oxidation. Same target as metformin and exercise.

Clinical trials

1
Alpha-Lipoic Acid for Diabetic Peripheral Neuropathy — Sydney 2

Multicenter clinical trial of ALA (600, 1,200, or 1,800 mg/day racemic) vs placebo in 181 diabetic peripheral neuropathy patients for 5 weeks.

181 diabetic neuropathy patients.

All ALA doses significantly improved Total Symptom Score (TSS) vs placebo. 600 mg/day optimal dose-response. Established ALA as evidence-based treatment for diabetic neuropathy. pooled analysis confirmed.

2
ALA for Glycemic Control — Multiple Trials

Multiple trials of ALA for glycemic control in T2DM and metabolic syndrome.

T2DM and metabolic syndrome patients.

Modest improvements in fasting glucose, HbA1c, insulin sensitivity. Effect smaller than metformin or other established diabetes therapies. Reasonable adjunct.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
GI distress (nausea, abdominal pain, heartburn).
Hypoglycemia — particularly with insulin/sulfonylureas.
Headache.
Skin rash rare.
Insulin autoimmune syndrome (Hirata's disease) — rare reports of severe hypoglycemia from ALA-induced anti-insulin antibodies; HLA-DRB1*04:06 genetic predisposition (more common in Japanese populations); reversible with ALA discontinuation.
Body odor (sulfur compound).

Important Drug interactions

Insulin / sulfonylureas — additive hypoglycemic effect; monitor blood glucose closely.
Metformin — generally compatible; modest additive.
Thyroid medications — theoretical reduced absorption; separate by 4 hours.
Chemotherapy — theoretical interactions; consult oncologist.
Mitochondrial toxic drugs — ALA may modestly reduce toxicity (theoretical).
Pre-surgery — discontinue 1-2 weeks before to avoid hypoglycemia during fasting.

Featured in these supplement guides

Blood Sugar Control→Energy & Fatigue→Fertility→

More Metabolic Health Ingredients

Metabolic Health
Psyllium Husk (Plantago ovata)
Psyllium husk is the soluble fiber derived from the seed husks of Plantago ovata — the mos…
Metabolic Health
Thiamine
Thiamine, also known as vitamin B1, is a water-soluble vitamin essential for converting ca…
Metabolic Health
Berberine
Berberine is a bioactive compound extracted from plants like barberry and goldenseal, know…
Metabolic Health
Inositol (Myo-Inositol)
Inositol is a naturally occurring sugar alcohol that acts as a secondary messenger in insu…

Explore Other Ingredients

Metabolic Health
Fenugreek
Fenugreek is an aromatic seed used both as a culinary spice and a supplement, best known f…
Antioxidant
Moringa
Moringa (Moringa oleifera) is a fast-growing tree whose leaves are dried into a nutrient-d…
Cardiovascular
CoEnzyme Q10
Coenzyme Q10 (CoQ10) is a lipid-soluble compound essential to mitochondrial ATP production…

Frequently asked questions about R-Lipoic Acid (Natural / Stabilized R-ALA)

What is R-lipoic acid?

R-lipoic acid is the natural, biologically active form of alpha-lipoic acid (ALA). Standard ALA supplements are a 50/50 mix of the R and S forms; R-lipoic acid provides only the active R form, so it is used at lower doses.

Is R-lipoic acid better than regular alpha-lipoic acid?

R-lipoic acid is the form the body actually makes and uses, and it may be more potent per milligram, so smaller doses can match larger doses of the mixed form. It is less stable and more expensive, however; both forms are used for similar antioxidant and blood-sugar goals.

How much R-lipoic acid should I take?

Because it is the active form, doses are lower than mixed ALA, often around 100 to 300 mg per day. Take it on an empty stomach for best absorption, as with regular ALA. Choose stabilized R-lipoic acid for shelf stability.

Is R-lipoic acid safe?

It is generally well tolerated; mild stomach upset can occur. Because it may lower blood sugar, people on diabetes medication should monitor levels and check with their doctor, as with any lipoic acid.

What is R-Lipoic Acid used for?

R-Lipoic Acid is researched primarily for Metabolic Health, Antioxidant, and Longevity. Alpha-lipoic acid has the strongest evidence base for any natural compound for diabetic peripheral neuropathy. Sydney 2 trial, Aladin III, and others established efficacy.

What is the recommended dosage of R-Lipoic Acid?

The clinically studied dose is 100-300 mg/day R-ALA (equivalent to ~200-600 mg racemic ALA); diabetic neuropathy 600 mg/day racemic or ~300 mg R-ALA; up to 1,200 mg/day racemic studied in trials Always follow the product label and check with a healthcare provider for personal advice.

Is R-Lipoic Acid safe, and does it have side effects?

For most healthy adults, R-Lipoic Acid is well tolerated at studied doses. Reported effects can include: Generally well-tolerated. GI distress (nausea, abdominal pain, heartburn). It may also interact with some medications. R-Lipoic Acid is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does R-Lipoic Acid interact with any medications?

Possible interactions include: Insulin / sulfonylureas — additive hypoglycemic effect; monitor blood glucose closely. Metformin — generally compatible; modest additive. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for R-Lipoic Acid?

NutraSmarts rates the evidence for R-Lipoic Acid as Strong (4 out of 5). It is backed by 2 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Carlson DA, Smith AR, Fischer SJ, Young KL, Packer L The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects Altern Med Rev. 2007;12(4):343-51.PubMedUsed to support: Backs the bioavailability claim for Na-R-ALA: the stabilized sodium R-lipoate salt produced markedly higher Cmax and AUC than unstabilized R-ALA or racemic ALA. Honesty: this is a pharmacokinetic absorption study only - it shows better blood levels, not any superior clinical outcome over cheaper racemic ALA.
  2. Ikuta N, Okamoto H, Furune T, Uekaji Y, Terao K, Uchida R, Iwamoto K, Miyajima A Bioavailability of an R-alpha-Lipoic Acid/gamma-Cyclodextrin Complex in Healthy Volunteers Int J Mol Sci. 2016;17(6):949. doi: 10.3390/ijms17060949.PubMedUsed to support: Backs the bioavailability/stability claim: complexing R-ALA with gamma-cyclodextrin improved its plasma exposure in humans, reflecting that unstabilized R-ALA has poor stability. Honesty: a formulation/PK study; it addresses absorption, not proof of clinical superiority of R-ALA.
  3. Keith DJ, Butler JA, Bemer B, Dixon B, Johnson S, Garrard M, Sudakin DL, Christensen JM Age and gender dependent bioavailability of R- and R,S-alpha-lipoic acid: a pilot study Pharmacol Res. 2012;66(3):199-206. doi: 10.1016/j.phrs.2012.05.002.PubMedUsed to support: Backs the bioavailability claim: directly compared sodium-R-ALA, unstabilized R-ALA and racemic R,S-ALA absorption across age/sex. Honesty: small pilot focused on plasma levels; outcome (neuropathy/glycemic) evidence cited for ALA was generated with racemic alpha-lipoic acid, not isolated R-ALA.
  4. Breithaupt-Grogler K, Niebch G, Schneider E, Erb K, Hermann R, Blume HH, Schug BS, Belz GG Dose-proportionality of oral thioctic acid--coincidence of assessments via pooled plasma and individual data Eur J Pharm Sci. 1999;8(1):57-65. doi: 10.1016/s0928-0987(98)00061-x.PubMedUsed to support: Backs the 'R-enantiomer is better absorbed' premise: after oral racemic thioctic acid, Cmax of the R-(+)-enantiomer was about 40-50% higher than the S-(-)-enantiomer. Honesty: this is enantioselective pharmacokinetics, supporting an absorption rationale only - it does not show R-ALA is clinically superior to racemic ALA.